Covid was the third leading cause of death in the U.S. last year, with only heart disease and cancer killing more
Sad stats, all top 3. but where is the drop in heart disease? It is possible
Related Articles
Contents | Science 376, 6600
COVER Humanity’s actions have committed us to a warming climate and limited our options for mitigation. Although there is no turning back, some paths are…
404 – Not Found – Professional Heart Daily | American Heart Association
Page Not Found We’re sorry, but this page is not available. You may also be interested in: Becoming a Member Becoming a Science Volunteer Meetings…
Genes may play role in heart attack risk during stressful times
ATLANTA — Adults genetically predisposed to high stress are more likely to have a heart attack during times of heightened stress, such as a major…
Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes – BMC Medicine
Hybrid closed-loop (HCL) systems seamlessly interface continuous glucose monitoring (CGM) with insulin pumps, employing specialised algorithms and user-initiated automated insulin delivery. This study aimed to…
How common infections can spark psychiatric illnesses in children
And why many doctors do not realise it
Many mental-health conditions have bodily triggers
Psychiatrists are at long last starting to connect the dots
Deprivation linked to higher second cancer risk among England breast cancer survivors
Cambridge study finds those from poorest areas have 35% higher risk of second non-breast cancer
Anne Chang on the burden of chronic respiratory diseases in Indigenous people – The Lancet Respiratory Medicine in conversation with
Dr Anne Chang discusses the burden of chronic respiratory diseases in Indigenous people.
Nutrition app MyFitnessPal announces tools for GLP-1 medication
The new offerings and content will help members taking GLP-1 medications maximize nutrient intake and access medication tracking, recipes and community forums.
Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE/PRAAS
Objectives Patients with chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature/proteasome-associated autoinflammatory syndrome (CANDLE/PRAAS) respond to the janus kinase inhibitor 1/2 inhibition with baricitinib…
